DivestmentAug 13, 2026, 05:23 PM
ResMed to Divest MatrixCare Business for $490M; Acquires Noctrix Health
AI Summary
ResMed Inc. announced a definitive agreement to sell its MatrixCare business for $490 million in an all-cash transaction, expected to close in the first quarter of fiscal year 2027. This strategic divestment aims to sharpen the company's focus on its core growth areas of sleep, breathing, and connected home-based healthcare. Additionally, ResMed acquired Noctrix Health, LLC in June 2026, expanding its clinical sleep health portfolio with a medical device for restless legs syndrome. The company's product portfolio saw devices contribute 51% and masks/accessories 37% to net revenues in fiscal year 2026.
Key Highlights
- ResMed agreed to sell its MatrixCare business for $490 million in an all-cash transaction.
- The divestment is expected to close in the first quarter of fiscal year 2027.
- Acquired Noctrix Health, LLC in June 2026, expanding its clinical sleep health portfolio.
- Devices accounted for approximately 51% of net revenues in fiscal year 2026.
- Masks, diagnostic products, and accessories accounted for approximately 37% of net revenues in fiscal year 2026.
- The company employs approximately 11,370 people and sells products in over 140 countries.
Price Impact
More from RMD